Iga Swiatek learned the outcome of her doping appeal just minutes after walking off the court following her quarterfinal victory at the Australian Open. The Polish star had been under scrutiny since testing positive for the banned substance trimetazidine (TMZ) in August 2024. The International Tennis Integrity Agency (ITIA) ruled that her positive test was due to a contaminated melatonin product, resulting in a no-fault verdict and a one-month suspension.
However, WADA had the option to appeal the decision, as they did in the case of World No. 1 Jannik Sinner, who is facing a two-year ban for a similar infraction. Swiatek, anxiously awaiting WADA’s decision, finally received news that the agency would not be appealing her case to the Court of Arbitration for Sport (CAS). The decision came just minutes after her match, allowing Swiatek to breathe a sigh of relief as she advanced further in the tournament without the looming cloud of an extended suspension.
Swiatek expressed her gratitude in a post-match interview, saying, “It’s been a tough few months dealing with this, but I’ve maintained my innocence from the start. I’m thankful that this chapter is behind me now, and I can focus entirely on my tennis.”
With the controversy settled, Swiatek can now shift her full attention to her Australian Open campaign, where she has been in excellent form, winning her matches in dominant fashion. She moves on to the semifinals with renewed focus and determination.
